Lupin is engaged in the business of Manufacture of Pharmaceuticals.
Financial Results:
Lupin Ltd reported Revenues for Q1FY24 of ₹4,814.00 Crores up from ₹3,744.00 Crore year on year, a rise of 28.58%.
Total Expenses for Q1FY24 of ₹4,279.00 Crores up from ₹3,748.00 Crores year on year, a rise of 14.17%.
Consolidated Net Profit of ₹453.00 Crores from -₹87.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹9.94, from -₹1.96 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.